Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07267273
NA

Betamethasone Phonophoresis For Vitiligo

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

Vitiligo is a skin disorder that results in the formation of depigmented patches or hypopigmented macules due to selective destruction or reduction of melanocytes the cells that produce pigment in our skin. Vitiligo affects 0.1-2% of the World's population. People of all skin types and all ages can be affecte. In most of the cases, white patches develop or expand slowly overtime, and in some cases it never progress and remains stable . Vitiligo can be segmental or non-segmental depending upon the morphology of the clinical involvement. It can also be classified as stable or unstable based on the activity of disease. Steroids act as anti-inflammatory and immunosuppressant agents. Even if different classes of steroids are now available, the mid- potent ones (e.g. betamethasone dipropionate 0.05% cream, 0.05% clobetasol propionate ointment) are usually preferred for the treatment of young patients . Now days, topical corticosteroids are the most commonly prescribed agents in treatment of dermatologic conditions .Almost all treatments of vitiligo have borrowed from therapies whose prime targets have been another disease.

Official title: Effect of Betamethasone Phonophoresis in Treatment of Vitiligo

Key Details

Gender

All

Age Range

25 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-11-10

Completion Date

2026-02-10

Last Updated

2025-12-05

Healthy Volunteers

No

Conditions

Interventions

DRUG

Beclomethasone

to determine the effect of betamethasone phonophoresis on vitiligo patients.

Locations (1)

Cairo University Hospital

Cairo, Egypt